[go: up one dir, main page]

GB1359560A - Preparation of pyrrylsalicylic acid - Google Patents

Preparation of pyrrylsalicylic acid

Info

Publication number
GB1359560A
GB1359560A GB890372A GB890372A GB1359560A GB 1359560 A GB1359560 A GB 1359560A GB 890372 A GB890372 A GB 890372A GB 890372 A GB890372 A GB 890372A GB 1359560 A GB1359560 A GB 1359560A
Authority
GB
United Kingdom
Prior art keywords
pyrrylsalicylic
preparation
acid
pyrryl
salicylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB890372A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to GB890372A priority Critical patent/GB1359560A/en
Publication of GB1359560A publication Critical patent/GB1359560A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1359560 5-N-Pyrryl salicylic acid MERCK & CO Inc 25 Feb 1972 8903/72 Addition to 1214079 Heading C2C 5-N-Pyrryl salicylic acid is prepared by one of the following reaction schemes Pharmaceutical compositions in conventional forms for oral administration and having antipyretic anti-inflammatory and analgesic activity comprise the above compound or salt thereof and a carrier or diluent.
GB890372A 1972-02-25 1972-02-25 Preparation of pyrrylsalicylic acid Expired GB1359560A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB890372A GB1359560A (en) 1972-02-25 1972-02-25 Preparation of pyrrylsalicylic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB890372A GB1359560A (en) 1972-02-25 1972-02-25 Preparation of pyrrylsalicylic acid

Publications (1)

Publication Number Publication Date
GB1359560A true GB1359560A (en) 1974-07-10

Family

ID=9861541

Family Applications (1)

Application Number Title Priority Date Filing Date
GB890372A Expired GB1359560A (en) 1972-02-25 1972-02-25 Preparation of pyrrylsalicylic acid

Country Status (1)

Country Link
GB (1) GB1359560A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133099B2 (en) 2005-07-22 2015-09-15 Nogra Pharma Limited Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
US9511041B2 (en) 2009-02-16 2016-12-06 Nogra Pharma Limited Alkylamido compounds and uses thereof
US9682050B2 (en) 2012-04-18 2017-06-20 Nogra Pharma Limited Methods of treating lactose intolerance
US9682923B2 (en) 2012-02-09 2017-06-20 Nogra Pharma Limited Methods of treating fibrosis
US9913817B2 (en) 2008-12-05 2018-03-13 Nogra Pharma Limited Methods for preventing or reducing colon carcinogenesis
US11905232B2 (en) 2019-02-08 2024-02-20 Nogra Pharma Limited Process of making 3-(4′-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9345680B2 (en) 2005-07-22 2016-05-24 Nogra Pharma Limited Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
US9561202B2 (en) 2005-07-22 2017-02-07 Nogra Pharma Limited Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
US9133099B2 (en) 2005-07-22 2015-09-15 Nogra Pharma Limited Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
US10016381B2 (en) 2005-07-22 2018-07-10 Nogra Pharma Limited Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
US9913817B2 (en) 2008-12-05 2018-03-13 Nogra Pharma Limited Methods for preventing or reducing colon carcinogenesis
US10398667B2 (en) 2009-02-16 2019-09-03 Nogra Pharma Limited Methods of treating hair related conditions
US9511041B2 (en) 2009-02-16 2016-12-06 Nogra Pharma Limited Alkylamido compounds and uses thereof
US10959970B2 (en) 2009-02-16 2021-03-30 Nogra Pharma Limited Methods of treating hair related conditions
US9901557B2 (en) 2009-02-16 2018-02-27 Nogra Pharma Limited Methods of treating hair related conditions
US10137101B2 (en) 2009-02-16 2018-11-27 Nogra Pharma Limited Alkylamido compounds and uses thereof
US11046641B2 (en) 2012-02-09 2021-06-29 Nogra Pharma Limited Methods of treating fibrosis
US9682923B2 (en) 2012-02-09 2017-06-20 Nogra Pharma Limited Methods of treating fibrosis
US11753365B2 (en) 2012-02-09 2023-09-12 Nogra Pharma Limited Methods of treating fibrosis
US12291494B2 (en) 2012-02-09 2025-05-06 Nogra Pharma Limited Methods of treating fibrosis
US9682050B2 (en) 2012-04-18 2017-06-20 Nogra Pharma Limited Methods of treating lactose intolerance
US11905232B2 (en) 2019-02-08 2024-02-20 Nogra Pharma Limited Process of making 3-(4′-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof

Similar Documents

Publication Publication Date Title
GB1322988A (en) Thiaheterocyclyl-acetic acid derivatives
GB1301973A (en)
GB1359560A (en) Preparation of pyrrylsalicylic acid
GB1471910A (en) Lysine salt
GB1530074A (en) Rho-acetamidophenol derivatives the preparation thereof and the use of such derivatives as therapeutic agents
GB1378068A (en) Citric acid derivatives
GB1261147A (en) Pentanedione derivatives
GB1394757A (en) Lysino-calcium chloride
GB1349138A (en) Quinazoline derivative
GB1187946A (en) Dimethylbiguanide Derivative
GB1488778A (en) Salt of alpha-methyl-(5-benzoyl-2-thiophene)-acetic acid processes for preparing it and compositions containing it
IE34590B1 (en) Phenylethanolamine derivatives
GB1451389A (en) Indolobenzazepines
GB1302353A (en)
GB1417807A (en) Pharmaceutically acitve compounds
GB1501592A (en) Pharmaceutical compositions
GB1319841A (en) Quinine alkaloid derivatives
GB1393228A (en) 2-2-2-methyl-5-nitro-1-imidazolyl-ethyl-2-thiopseudoureas and related compounds
GB1219387A (en) Bicyclo[2.2.2]oct-2-ene-amino acid compounds
GB1276719A (en) Benzomorphan derivatives and their salts
GB1284423A (en) Cyclohexa-1,4-diene-1-acetic acids
GB1412094A (en) Pharmaceutical compositions containing p-chlorohippuric acid or salts thereof
GB1425911A (en) Phenylacetic acid derivatives, process for their preparation and therapeutic composition containing same
GB1261660A (en) alpha-HYDRAZINO ACIDS
GB1230468A (en)

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee